Abstract: Herpes simplex virus type 1 (HSV-1) is a commonly occurring human pathogen worldwide. There is an urgent need to discover and develop new alternative agents for the management of HSV-1 infection. Tripterygium hypoglaucum (level) Hutch (Celastraceae) is a traditional Chinese medicine plant with many pharmacological activities such as anti-inflammation, anti-tumor and antifertility. The usual medicinal part is the roots which contain about a 1% yield of alkaloids. A crude total alkaloids extract was prepared from the roots of T.
Herpes simplex virus type 1 (HSV-1) is a DNA virus with rapid proliferation and high infectivity. It is a common human pathogen that occurs worldwide with 60% to 95% of infection in adults, and is responsible for a broad range of human infectious diseases such as gingiva-stomatitis, keratitis, cutaneous herpes, genital herpes and encephalitis [17, 18] .
Herpes simplex virus infections are usually managed with anti-viral drugs such as acyclovir, vidarabine and phosphonoformic acid [12] . However, undesirable complications and the emergence of drug-resistant virus strains necessitate the development of alternative agents for the management of HSV infections [7, 11] .
Chinese traditional knowledge and practices play an important role in the discovery and development of safe and effective drugs. Natural products remain a consistently successful source in drug discovery and may offer many opportunities to find anti-HSV drugs or lead compounds [5, 20] . A variety of natural products have been found effective on inhibiting unique enzymes and proteins crucial to the virus life cycle [2, 21] . The plant Tripterygium hypoglaucum (level) Hutch (Celastraceae) is distributed along the South bank of the Yangtze River and in Southwest regions of China. It has been used as a traditional medicine with the pharmacological activities of anti-inflammation, antitumor, antifertility and immunosuppression, and employed for the treatment of rheumatoid arthritis, acute infectious hepatitis, chronic nephritis, leukaemia, erythematous lupus, and neurodermatitis [4] . The medicinal part of T. hypoglaucum is its roots with principal active components of alkaloids, terpenoids and tannins [10] . The content of total alkaloids in the root is about 1% which is obviously higher than in the stem.
The compounds purified from root methanol extracts, such as triptonine A, hypoglaunine A, hypoglaunine B and hyponine E, were reported to be active in anti-HIV virus [8] . A primary investigation was carried out on the treatment of viral keratitis with the preparation of T. hypoglaucum.
In this paper, the in vitro anti-HSV-1 activity of the total alkaloids extract from T. hypoglaucum was evaluated at the cellular and molecular level.
MATERIALS AND METHODS

Reagents
Reagents for cell culture, such as DMEM medium, fetal bovine serum (FBS), EDTA and HEPES were purchased from GIBCO. Dimethyl sulfoxide (DMSO), 
Preparation of the total alkaloids extract
The harvested roots of T. hypoglaucum were washed, dried and powdered. A thousand grams of powdered material was extracted with 85% ethanol by maceration for 1 h and under hot reflux for 3×1 h, [15] . Titer of the virus stock was 10 5.5 TCID 50 /mL.
Cytotoxicity assay
The cytotoxicity of the total alkaloids extract on Vero cells was evaluated before antiviral activity assay by MTT method as described elsewhere [13] .
Briefly, cells (2×10 5 /mL) were seeded in a 96-well tissue culture plate and incubated at 37°C in 5% 
Antiviral activity by CPE assay
Antiviral activity of the total alkaloids extract was determined according to the inhibitory capacity against the viral cytopathic effect [24] . 
Plaque inhibition assay
Vero cells (2×10 5 /mL) were seeded in a 96-well plate and incubated in 5% CO 2 at 37°C for 24 h to form confluent monolayers. The medium was discarded, then cells were inoculated with 100 μL of highly diluted HSV-1 virus supplemented with 100 μL of the total alkaloid extract (positive control, virus control and cell control were also set), and left to adsorb for 1 h at room temperature on a tray shaker.
After adsorption, the inoculate was replaced with When PCR reaction was complete, 6 μL of the products were identified by electrophoresis with 1% agarose gel, then the gel profiles were scanned and analyzed with the Bioimaging System (SYNGENE).
The ratio value of the integrated optical density of aimed gene to that of GAPDH was assessed as the indication of gene expression level.
RESULTS
Cytotoxicity of the total alkaloids extract
Cytotoxicity of the crude alkaloids extract against
Vero cells was measured in order to gauge antiviral selectivity by MTT assay after a 48 h of co-incubation with drug dilutions. The cytotoxic concentration that Table 2 ).
Inhibition activity of the total alkaloids extract against HSV-1 viral CPE
The inhibition activity of the alkaloids extract from
T. hypoglaucum against HSV-1 induced CPE was investigated and results are shown in Table 3 . The results indicate that the alkaloids extract possessed a potent inhibitory activity against HSV-1 with an IC 50 value of 6.5 μg/mL which was notably lower than that of Acyclovir (15.4 μg /mL).
Plaque reduction effect of the extract
The improved Antiviral activity of the alkaloids extract compared to Acyclovir was further confirmed by plaque inhibition assay. The results (Table 4) show that the extract significantly reduced the viral plaque formation at a low concentration of 6.25 μg/mL to 12.5 μg/mL with the plaque reduction ratio of 55% to 75% which was 35% higher than that of Acyclovir at the same concentration, and the inhibition activity showed an obvious dosage dependence.
Inhibition effect of the extract on gene expression
Before investigating the inhibition effect of the extract on gene expression, a growth curve of HSV-1 virus proliferation was determined (Fig. 1) . Intracellular virus titers increased continually from 1 h to 24 h after inoculation, but extracellular virus titers were constant at this stage, subsequently, both titers increased and reached peak values at 72 h. Based on this result, cells were harvested at 24 h after virus infection and gene expression levels were measured.
Three characteristic bands of the total RNA extracts were clearly visible on agarose gel after electrophoresis.
RT-PCR results of electrophoresis gel profiles and the integrated optical density ratio of cDNA bands are shown in Fig. 2 and Fig. 3 . At the same concentration of 12.5 μg/mL, Acyclovir showed almost complete expression inhibition to all the 3 detected virus genes.
The alkaloids extract also showed high inhibition activity against the expression of the 3 genes at 12.5 μg/mL, with an inhibition efficacy of 74.6% (UL30), 70.9% (UL39) and 62.6% (US6) respectively compared to the virus control.
DISCUSSION AND CONCLUSIONS
Botanical extracts exhibit a wide spectrum of Cell viability (%, mean±S.D., n=3); others the same. biological and pharmacological properties, including cytoprotection, anticancer, anti-inflammation, immunomodulation and anti-infection [14, 22] . Such medicinal plants provide an important source for antiviral drug screening and development [6, 1, 9] .
The components of T. hypoglaucum are complex, but the main medicinal content in the root has been identified to comprise alkaloids. In this study, we found that cytotoxicity of the crude alkaloid extract was larger than for Acyclovir (ACV),with a TI of 7.17 compared to 54.63 for ACV (Table 3 ). This showed the drug safety of the crude alkaloids extract was less than ACV's. But the crude alkaloids extract displayed significant activity against HSV-1 and inhibited the proliferation of HSV-1 in Vero cells. Its IC 50 was lower than that of Acyclovir (Table 3) , and presented notably higher plaque reduction efficacy than Acyclovir at a concentration range of 6.25 to 12.5 μg/mL (Table 4) [19] . UL30 is a type of IE gene that codes virus DNA polymerase, UL39 is also an IE gene encoding a subunit of virus ribonucleotide reductase, they play important role in virus genome replication. US6 is a L gene encoding glycoprotein gD which is the main component of virus envelope and acts later role in entry.
The functions of about half the HSV-1 coded proteins have been shown to be absolutely necessary for successful lifecycle [16] . Any one of these indispensable virus proteins identifies a possible target for antiviral intervention. The most successful antiviral directed against HSV to date is Acyclovir.
Acyclovir interacts specifically and sequentially with the proteins coded by UL23 and UL30. Acyclovir is phosphorylated to its active form by the viral encoded thymidine kinase where it acts as a chain terminator of the viral DNA polymerase there by stopping any further viral replication [3, 23] .
In the present study, transcription levels of the 3 key genes UL30, UL39 and US6 were semi-quantified by RT-PCR assay (Fig. 2, Fig. 3 ). Under treatment with T.
hypoglaucum alkaloids extract at a concentration of 12.5 μg/mL, the transcription of genes UL30, UL39
and US6 was significantly inhibited by an inhibition efficacy of 74.6% (UL30), 70.9% (UL39) and 62.6% (US6) respectively contrasted to virus control, which further confirmed the potent antiviral activity against HSV-1 replication though lower than that of Acyclovir. Value in vertical axis was the ratio of the integrated optical density of the amplificated cDNA band to that of the inner control GAPDH. Alk: total alkaloids extract; ACV: Acyclovir.
a Plaque inhibition ratio to virus control, shown as mean±S.
D. (n=3).
In conclusion, the total alkaloids extract of the medicinal plant T. hypoglaucum presented potent anti-HSV-1 activity and low cytotoxicity in Vero cells. It is worthwhile to do further works on the identification of potential active compounds and the investigation of action mechanism.
